{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T10:36:55Z","timestamp":1789468615357,"version":"build-2803163510"},"reference-count":38,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2008,3,12]],"date-time":"2008-03-12T00:00:00Z","timestamp":1205280000000},"content-version":"vor","delay-in-days":4699,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[1995,5]]},"abstract":"<jats:p>The aim of this study was to evaluate the possible prognostic relevance of thymidine kinase serum levels (s\u2010TK), an indirect marker of proliferative activity, in myelodysplastic syndromes (MDS). S\u2010TK levels were monitored by means of a radioenzyme assay in 90 patients affected by MDS (22 refractory anaemia, RA; 17 RA with ring sideroblasts, RARS; 21 RA with blast excess, RAEB; 15 RAEB in transformation, RAEB\u2010T; 15 chronic myelomono\u2010cytic leukaemia, CMMoL). Mean s\u2010TK levels (U\/\/tl) measured at diagnosis were 11\u20139 \u201312\u20136 for RA, 11\u20134\u201313\u20326 for RARS, 19\u20139 \u2013 28\u20134 for RAEB, 39\u20136 \u2013 34\u20133 for RAEB\u2010T and <jats:italic>77\u20137 \u2013<\/jats:italic> 69\u20137 for CMMoL (normal values &lt;5U\/\/LI1). With the only exception of a weak relationship with lactate dehydrogenase, no correlation was found between initial s\u2010TK values and other clinical or laboratory parameters, such as age, haemoglobin, white blood cell or platelet count, percentage of bone marrow blasts. MDS patients with s\u2010TK &gt;38 <jats:italic>V\/fA<\/jats:italic>, a cut\u2010off level selected by means of ROC statistical analysis, showed a significantly shorter survival than those with s\u2010TK &lt;38U\/\/xl (8\u20132 v 37\u20134 months, respectively; P &lt; 0\u20130001). In particular, transformation in acute myeloid leukaemia (AML) occurred in 17\/21 (81%) of patients with s\u2010TK &gt;38U\/\/d and 9\/69 (13%) of those with lower levels at diagnosis (P &lt; 00001), independently of FAB subtype. High s\u2010TK levels were also useful to predict evolution in AML during the course of the disease in patients with normal initial values. Multivariate analysis confirmed the independent prognostic value of s\u2010TK on both overall survival and risk of acute transformation. We conclude that s\u2010TK may be an important prognostic factor in MDS, strongly correlated with development of AML.<\/jats:p>","DOI":"10.1111\/j.1365-2141.1995.tb03390.x","type":"journal-article","created":{"date-parts":[[2008,3,12]],"date-time":"2008-03-12T11:34:36Z","timestamp":1205321676000},"page":"125-130","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Prognostic relevance of serum thymidine kinase in primary myelodysplastic syndromes: relationship to development of acute myeloid leukaemia"],"prefix":"10.1111","volume":"90","author":[{"given":"PELLEGRINO","family":"MUSTO","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CARLO","family":"BODENIZZA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ANTONIETTA","family":"FALCONE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GIOVANNI","family":"D'ARENA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"POTITO","family":"SCALZULLI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GIANNI","family":"PERLA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SERGIO","family":"MODONI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LUIGI","family":"PARLATORE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MARIA ROSA","family":"VALVANO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MARIO","family":"CAROTENUTO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,3,12]]},"reference":[{"key":"e_1_2_1_2_1","first-page":"245","article-title":"Serum thymidine kinase in acute non\u2010lymphoblastic leukemia","volume":"2","author":"Archimbaud E.","year":"1988","journal-title":"Leukemia"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19940115)73:2<322::AID-CNCR2820730215>3.0.CO;2-E"},{"key":"e_1_2_1_4_1","first-page":"52","article-title":"Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system","volume":"6","author":"Aul C","year":"1992","journal-title":"Leukemia"},{"key":"e_1_2_1_5_1","first-page":"55","volume-title":"Attualita' in Ematologia 1994","author":"Bartl R.","year":"1994"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8588(18)30328-9"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-4827(74)90790-3"},{"key":"e_1_2_1_8_1","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2141.1982.tb08475.x","article-title":"Proposal for the classification of myelodysplastic syndromes","volume":"51","author":"Bennett J.M.","year":"1982","journal-title":"British Journal of Haematology"},{"key":"e_1_2_1_9_1","first-page":"141","article-title":"Myelodysplastic syndromes: a multiparametric study of prognostic factors and proposed scoring system","volume":"75","author":"Cassano E.","year":"1990","journal-title":"Haematologica"},{"key":"e_1_2_1_10_1","first-page":"19","article-title":"Serum deoxythymidine kinase as a progressive marker of hematological malignancy","volume":"52","author":"Doi S.","year":"1990","journal-title":"Nagoya Journal of Medical Sciences"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1987.tb02318.x"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.3109\/02841868509134381"},{"key":"e_1_2_1_13_1","first-page":"587","article-title":"Clinical course of myelodysplastic syndromes","volume":"6","author":"Ganser A.","year":"1992","journal-title":"Hematology \/Oncology Clinics of North America"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/0145-2126(90)90133-T"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1984.82"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01715117"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.42.5.498"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19841201)54:11<2450::AID-CNCR2820541123>3.0.CO;2-R"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19920315)69:6<1368::AID-CNCR2820690611>3.0.CO;2-R"},{"key":"e_1_2_1_20_1","first-page":"31","article-title":"Serum thymidine kinase in hematologic malignancies","volume":"73","author":"Luoni R.","year":"1988","journal-title":"Haematologica"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830430302"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19831001)52:7<1190::AID-CNCR2820520711>3.0.CO;2-R"},{"key":"e_1_2_1_23_1","first-page":"1315","article-title":"Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases","volume":"7","author":"Morel P.","year":"1993","journal-title":"Leukemia"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1990.tb00425.x"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8588(18)30330-7"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1985.tb07329.x"},{"key":"e_1_2_1_27_1","first-page":"545","article-title":"Thymidine kinase in neoplastic haemato\u2010logical diseases: confirmations, doubts and new findings. (Letter)","volume":"73","author":"Musto P.","year":"1988","journal-title":"Haematologica"},{"key":"e_1_2_1_28_1","first-page":"493","article-title":"Modifications of erythropoieis in myelodysplastic syndromes treated with recombinant erythropoietin as evaluated by soluble transferrin receptor, high fluorescence reticulocytes and hypochromic erythrocytes","volume":"79","author":"Musto P.","year":"1994","journal-title":"Haematologica"},{"key":"e_1_2_1_29_1","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1182\/blood.V84.5.1687.1687","article-title":"G\u2010CSF and erythropoietin for the anemia of myelodysplastic syndromes: a real improvement with respect to erythropoietin alone? (Letter)","volume":"84","author":"Musto P.","year":"1994","journal-title":"Blood"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/0268-960X(93)90019-Z"},{"key":"e_1_2_1_31_1","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1182\/blood.V82.2.590.590","article-title":"N\u2010ras mutations are associated with poor prognosis and increased risk of leukemia in myelodysplastic syndromes","volume":"82","author":"Paquette R.L.","year":"1993","journal-title":"Blood"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428199409049656"},{"key":"e_1_2_1_33_1","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1182\/blood.V74.1.395.395","article-title":"Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 3 70 patients","volume":"74","author":"Sanz G.F.","year":"1989","journal-title":"Blood"},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830460103"},{"key":"e_1_2_1_35_1","first-page":"963","article-title":"High expression of the multidrug resistance p\u2010glycoprotein in high risk myelodysplasia is associated with immature phenotype","volume":"7","author":"Sonneveld P.","year":"1993","journal-title":"Leukemia"},{"key":"e_1_2_1_36_1","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1182\/blood.V81.11.3022.3022","article-title":"Mutations of the p\u201053 gene in myelodysplastic syndrome (MDS) and MDS\u2010derived leukemia","volume":"81","author":"Sugimoto K.","year":"1993","journal-title":"Blood"},{"key":"e_1_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1984.tb06079.x"},{"key":"e_1_2_1_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2900030108"},{"key":"e_1_2_1_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1988.tb04173.x"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.1995.tb03390.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.1995.tb03390.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T03:28:02Z","timestamp":1698377282000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.1995.tb03390.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,5]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1995,5]]}},"alternative-id":["10.1111\/j.1365-2141.1995.tb03390.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.1995.tb03390.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,5]]},"assertion":[{"value":"2008-03-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}